Dimethylacetamide Explained

Dimethylacetamide (DMAc or DMA) is the organic compound with the formula CH3C(O)N(CH3)2. This colorless, water-miscible, high-boiling liquid is commonly used as a polar solvent in organic synthesis. DMA is miscible with most other solvents, although it is poorly soluble in aliphatic hydrocarbons.

Synthesis and production

DMA is prepared commercially by the reaction of dimethylamine with acetic anhydride or acetic acid. Dehydration of the salt of dimethylamine and acetic acid also furnishes this compound:

CH3CO2H·HN(CH3)2 → H2O + CH3CON(CH3)2

Dimethylacetamide can also be produced by the reaction of dimethylamine with methyl acetate.[1]

The separation and purification of the product is carried out by multistage distillation in rectification columns. DMA is obtained with essentially quantitive (99%) yield referred to methyl acetate.[1]

Reactions and applications

The chemical reactions of dimethylacetamide are typical of N,N-disubstituted amides. Hydrolysis of the acyl-N bond occurs in the presence of acids:

CH3CON(CH3)2 + H2O + HCl → CH3COOH + (CH3)2NH2+ClHowever, it is resistant to bases. For this reason DMA is a useful solvent for reactions involving strong bases such as sodium hydroxide.

Dimethylacetamide is commonly used as a solvent for fibers (e.g., polyacrylonitrile, spandex) or in the adhesive industry. It is also employed in the production of pharmaceuticals and plasticizers as a reaction medium.

A solution of lithium chloride in DMAc (LiCl/DMAc) can dissolve cellulose. Unlike many other cellulose solvents, LiCl/DMAc gives a molecular dispersion, i.e. a "true solution". For this reason, it is used in gel permeation chromatography to determine the molar mass distribution of cellulose samples.

Dimethylacetamide is also used as an excipient in drugs, e.g. in Vumon (teniposide), Busulfex (busulfan) or Amsidine (amsacrine).

Toxicity

Dimethylacetamide, like most simple alkyl amides, is of low acute toxicity. Chronic exposure can cause hepatotoxicity.[2] [3] [4] [5] At high doses (400 mg/kg body mass daily), dimethylacetamide causes effects on the central nervous system (e.g. depression, hallucinations and delusion).[2] [6] [7]

Dimethylacetamide may be incompatible with polycarbonate or ABS. Devices (e.g. syringes) that contain polycarbonate or ABS can dissolve when coming into contact with dimethylacetamide.[8]

Regulation

In 2011, dimethylacetamide was identified in the EU as a Substance of very high concern (SVHC) because of its reproductive toxicity.[9] In 2014, the European Commission has started an investigation to restrict the use of dimethylacetamide in the EU according to REACH.[10]

In 2015, the CNESST (Committee on Standards, Equity, Health and Safety at Work in Quebec) has adopted a tightened classification of dimethylacetamide:[11]

Description Category GHS hazard statement
Reproductive toxicity 2Suspected of damaging fertility or the unborn child (H361)
Specific target organ toxicity – repeated exposure 2May cause damage to organs through prolonged or repeated exposure (H373)
Serious eye damage/eye irritation 2Causes serious eye irritation (H319)
Acute toxicity – inhalation 3Toxic if inhaled (H331)
Specific target organ toxicity – single exposure – narcotic effects 3May cause drowsiness or dizziness (H336)
Flammable liquid 4Combustible liquid (H227)

External links

Notes and References

  1. Web site: Grafmans . Horst . Maas . Steffen . Weck . Alexander . Rütter . Heinz . Schulz . Michael . Ross . Karl-Heinz . Method for the production of n,n-dimethylacetamide (DMAC) . Google Patents . BASF SE . 18 July 2019.
  2. U.S. Department of Health and Human Services & U.S. Department of Labor (1978) Occupational Health Guideline for Dimethyl Acetamide. Now: Occupational Health Guideline for Chemical Hazards. DHHS (NIOSH) Publication Number 81-123. January 1981. The National Institute for Occupational Safety and Health (NIOSH).
  3. Baum, S. L. . Suruda, A. J. . Toxic Hepatitis from Dimethylacetamide . International Journal of Occupational and Environmental Health . 1997 . 3 . 1 . 1–4 . 10.1179/oeh.1997.3.1.1 . 9891094 .
  4. Lee, C.-Y. . Jung, S.-J. . Kim, S.-A. . Park, K.-S. . Ha, B.-G. . Incidence of dimethylacetamide induced hepatic injury among new employees in a cohort of elastane fibre workers . Occupational and Environmental Medicine . 2006 . 63 . 10 . 688–693 . 10.1136/oem.2005.023580 . 16728503 . 2078052 .
  5. Gong, W. . Liu, X. . Zhu, B. . Dimethylacetamide-induced occupational toxic hepatitis with a short term recurrence: a rare case report . Journal of Thoracic Disease . 2016 . 8 . 6 . E408–E411 . 10.21037/jtd.2016.04.44 . 27293868 . 4885965 . free .
  6. Weiss, A. J. . Jackson, L. G. . Carabasi, R. A. . Mancall, E. L. . White, J. C. . A Phase I Study of Dimethylacetamide . Cancer Chemotherapy Reports . 1962 . 16 . February 1962 . 477–485 . 14005853.
  7. Weiss, A. J. . Mancall, E. L. . Koltes, J. A. . White, J. C. . Jackson, L. G. . Dimethylacetamide: A Hitherto Unrecognized Hallucinogenic Agent . Science . 1962 . 136 . 3511 . 151–152. 10.1126/science.136.3511.151. 14005854. 1962Sci...136..151W . 20098340 .
  8. https://www.fda.gov/drugs/drugsafety/ucm437469.htm FDA warns health care professionals not to use Treanda Injection (solution) with closed system transfer devices, adapters, and syringes containing polycarbonate or acrylonitrile-butadiene-styrene
  9. http://echa.europa.eu/documents/10162/13638/agreement_dmac_20111124_en.pdf Agreement of the Member State Committee on the Identification of N,N-Dimethylacetamide (DMAC) as a Substance of Very High Concern – Adopted on 24 November 2011
  10. http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32014R0895&from=EN Commission Regulation (EU) No 895/2014
  11. Commission des normes, de l'équité, de la santé et de la sécurité du travail (CNESST), Quebec, Canada: WHMIS 2015 classification of N,N-Dimethylacetamide.